Fetal Fibronectin Linked Network Detection Kit

Test for detection of fetal fibronectin in cervicovaginal secretions during pregnancy. Assists in assessment of preterm delivery risk in pregnant women.

This kit is suitable for qualitative detection of fetal fibronectin (fFN) in pregnant women's vaginal secretions. It is clinically used for auxiliary detection of preterm labor.

Detection kit for qualitative detection of fetal fibronectin and insulin-like growth factor binding protein-1 using immunochromatographic method.

A diagnostic kit for counting and analyzing fetal cells in maternal circulation. Used in prenatal diagnosis to detect and quantify fetal cells for assessment of maternal-fetal hemorrhage and fetal status. Available variants: Fetal Cell Count™ Kit.

Testing system for perinatal disease screening and risk assessment in pregnant women and newborns. Supports maternal-fetal health monitoring protocols.

Non-invasive prenatal testing kit for detection of trisomy 21, 18, and 13 using reversible termination sequencing technology. Provides chromosomal abnormality screening during pregnancy.

Immunodiagnostic kit for detecting fetal membrane rupture markers in vaginal secretions of pregnant women. Provides rapid dual-indicator quantitative analysis to diagnose premature rupture of membranes and predict preterm labor risk.

Non-invasive prenatal testing kit for detecting fetal chromosomal abnormalities (trisomy 21, 18, and 13) using reversible termination sequencing technology. Provides rapid genetic screening from maternal blood samples during pregnancy with high sensitivity and specificity for aneuploidy detection.

A detection kit measuring placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) using magnetic microparticle chemiluminescence methodology. These two biomarkers together form a comprehensive preeclampsia screening and prevention solution for the entire pregnancy period, with the kit being used in early pregnancy assessment as part of multiple factor screening protocols.

In vitro diagnostic kit for detecting fetal RhD status in RhD-negative pregnant women. Enables optimized clinical management of maternal-fetal incompatibility and hemolytic disease prevention in newborns. Provides reliable, precise results for immunohematology laboratories.

A non-invasive fetal RHD genotyping diagnostic test kit designed to optimize care management for RhD negative pregnant women. This kit enables reliable and early fetal RhD typing from maternal blood samples without invasive procedures.

A detection test kit for measuring placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) using magnetic microparticle chemiluminescence method. This product is used for preeclampsia screening and prevention throughout pregnancy.